Department of Immunology, The Fourth Military Medical University, Xincheng District, Xi'an, Shaanxi, P. R. China.
Department of Microbiology, The Fourth Military Medical University, Xi'an, P. R. China.
Ann Med. 2023;55(2):2247000. doi: 10.1080/07853890.2023.2247000.
Hantaan virus (HTNV) infection can cause severe hemorrhagic fever with renal syndrome (HFRS). Inflammatory monocytes (iMOs) are involved in early antiviral responses. Previous studies have found that blood iMOs numbers increase in the acute phase of HFRS. Here, we further identified the phenotypic characteristics of iMOs in HFRS and explored whether phenotypic changes in iMOs were associated with HFRS severity.
Blood samples from 85 HFRS patients were used for phenotypic analysis of iMOs by flow cytometry. Plasma HTNV load was determined using RT-PCR. THP-1 cells overexpressing CD226 were used to investigate the effects of CD226 on HLA-DR/DP/DQ and CD80 expression. A mouse model was used to test macrophage phenotype following HTNV infection.
The proportion of CD226 iMOs in the acute phase of HFRS was 66.83 (35.05-81.72) %, which was significantly higher than that in the convalescent phase (5.32 (1.36-13.52) %) and normal controls (7.39 (1.15-18.11) %) ( < 0.0001). In the acute phase, the proportion of CD226 iMOs increased more in patients with more severe HFRS and correlated positively with HTNV load and negatively with platelet count. Notably, CD226 iMOs expressed lower levels of HLA-DR/DP/DQ and CD80 than CD226 iMOs, and overexpression CD226 could enhance the expression of HLA-DR/DP/DQ and CD80. In a mouse model, HTNV also induced the expansion of CD226 macrophages, with decreased expression of I-A/I-E and CD80.
CD226 iMOs increased during HTNV infection and the decrease in CD226 hampered the expression of HLA-DR/DP/DQ and CD80, which may promote the immune escape of HTNV and exacerbate clinical symptoms.
汉坦病毒(HTNV)感染可引起严重的肾综合征出血热(HFRS)。炎性单核细胞(iMOs)参与早期抗病毒反应。先前的研究发现,HFRS 的急性期血液 iMOs 数量增加。在这里,我们进一步鉴定了 HFRS 中 iMOs 的表型特征,并探讨了 iMOs 的表型变化是否与 HFRS 严重程度有关。
使用流式细胞术分析 85 例 HFRS 患者的血液样本,以鉴定 iMOs 的表型。使用 RT-PCR 测定血浆 HTNV 载量。使用过表达 CD226 的 THP-1 细胞来研究 CD226 对 HLA-DR/DP/DQ 和 CD80 表达的影响。使用小鼠模型检测 HTNV 感染后巨噬细胞的表型。
HFRS 急性期 CD226 iMOs 的比例为 66.83(35.05-81.72)%,明显高于恢复期(5.32(1.36-13.52)%)和正常对照组(7.39(1.15-18.11)%)( < 0.0001)。在急性期,HFRS 更严重的患者中 CD226 iMOs 的比例增加更多,且与 HTNV 载量呈正相关,与血小板计数呈负相关。值得注意的是,与 CD226 iMOs 相比,CD226 iMOs 表达的 HLA-DR/DP/DQ 和 CD80 水平较低,而过表达 CD226 可增强 HLA-DR/DP/DQ 和 CD80 的表达。在小鼠模型中,HTNV 也诱导了 CD226 巨噬细胞的扩增,同时降低了 I-A/I-E 和 CD80 的表达。
HTNV 感染期间 CD226 iMOs 增加,而 CD226 的减少阻碍了 HLA-DR/DP/DQ 和 CD80 的表达,这可能促进了 HTNV 的免疫逃逸并加重了临床症状。